5 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPCmCRPCActive, not recruitingPhase 32026-09-29NCT03395197
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trialprostate adenocarcinomaActive, not recruitingPhase 32026-08-17NCT05050084
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT TrialGenital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate adenocarcinoma, prostate cancer, prostate disorderActive, not recruitingPhase 32026-08-17NCT04513717
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent IohexolMalignant Solid NeoplasmActive, not recruitingPhase 12026-08-07NCT03997370
Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast CancerNeoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, breast carcinoma in situ, breast disorder, breast neoplasm, carcinoma, epithelial neoplasm, in situ carcinoma, invasive breast carcinoma, neoplasm, skin disorderActive, not recruitingNot applicable2026-01-22NCT04871516